Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop

Mol Ther. 2008 Jun;16(6):1006-8. doi: 10.1038/mt.2008.70.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Clinical Trials as Topic
  • Drug Approval
  • Drug Design
  • Drug Industry / methods
  • Gene Expression Regulation*
  • Genetic Engineering
  • Genetic Therapy / methods*
  • Humans
  • Models, Biological
  • Neoplasms / therapy*
  • Oncolytic Virotherapy / methods*
  • Oncolytic Virotherapy / trends*
  • Oncolytic Viruses / metabolism*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab